Navigation Links
MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse

RIDGE, N.Y., Oct. 21 /PRNewswire/ -- What's the cost of saving a teenage life? When it comes to preventing accidental death resulting from prescription medication abuse, there's no price tag. Parents with good intentions, however, may be unaware that the lock-boxes they've installed are not protecting their teens from the ticking timebomb of prescription drugs. That's why MEDNET(TM), a national leader in premium-quality medical supplies, has formed an exclusive partnership with Axius Healthcare Group to distribute MedSafe(TM), the most secure medical safe on the market today.

"MedSafe is a real safe, setting it apart from medicine cabinets and other inferior lock-box products," says Lorraine Yarde, principal of the Axius MedSafe division of Axius Healthcare Group, which manufactures products that prevent loss in the healthcare industry and address patient safety concerns. "We've been developing this safe for five years in response to specific consumer demand. MedSafe is much more than a deterrent - it's peace of mind for parents, grandparents and caretakers, and provides real protection against prescription drug abuse."

Made of high-grade steel, MedSafe ( features a biometric fingerprint reader, so its contents are accessible only to the parent or person who programs the safe. MedSafe technology is proven: it has been used in the healthcare industry for years, securing medications in doctors' offices nationwide. Moreover, it is the number-one choice for gun enthusiasts and law enforcement officers to store handguns in the home, winning endorsements from the National Rifle Association and The Handgun Club of America. Other lock-box products available on the market today, made from plastic and using confusing combination locks or mechanical keys, do not stand up to the durable steel and high-tech security features of the original MedSafe.

"MedSafe is secure enough to store a loaded weapon, and that's exactly what a prescription drug is when it winds up in the hands of teens and is abused," says Rob Perissi, MEDNET's president. "The parallel is uncanny but pertinent, considering that one in five teens has abused a prescription pain medication, and one in 10 has abused cough medicine. Preventing access to such medications is our goal through this partnership with Axius. MedSafe is the best solution available with a proven record of over five years."

MEDNET is the exclusive distributor of MedSafe, available in two sizes. MedSafe is ideal not only for homes but anywhere prescription and over-the-counter medications are stored in proximity of children and teens, including daycares, schools, camps and more.

About MEDNET Direct Corp.

Leveraging technology to move products from manufacturer to buyer in the most efficient manner possible, MEDNET strives to save customers time and money. The company accomplishes this by direct supply through leading U.S. manufacturers of premium quality medical supplies. Such partnerships, plus MEDNET's cutting-edge customer service, guarantee savings to customers, helping them gain that crucial competitive edge in the disposable medical supply marketplace. For more information, please visit

About Axius Healthcare Security Solutions

With over 20 years of experience in healthcare technology and security, Axius' mission is to save families the pain and heartache caused by the abuse of prescription medications by providing the most secure products to safeguard prescription medications. The original MedSafe is just one product from a comprehensive line of solutions incorporating biometrics to improve safety in homes and healthcare settings. Located in Long Island, NY, Axius has design and engineering teams around the world. For more information, please visit


    Kerry Perissi
    Vice-President of Sales & Marketing
    MEDNET Direct Corp.

This release was issued through eReleases(TM). For more information, visit


Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse
2. CareFusion Launches 10-Pound High-Performance Critical Care Ventilator in the U.S.
3. CareFusion Launches EnVe(TM) Ventilator: 10-Pound High-Performance Critical Care Ventilator
4. NIDCR launches the FaceBase Consortium
5. KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue
6. Springer launches SpringerImages
7. ESHRE launches international study of polar body screening
8. Nutricia launches Nutra Neocate, weaning product designed for cows’ milk protein allergy
9. Swiss Initiative in Systems Biology launches new projects
10. Springer launches
11. Springer launches
Post Your Comments:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology: